http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2279432-C2
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5025 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- |
| filingDate | 1994-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2006-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91270dbe5c987c089d10e97737dc2e7d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8993eb738f869019540b1ae99cbafcf2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1e5ce5f27bdce9400b075058614307e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01e89690074852f789993d0443318397 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fbbc99445d4f1d03274038f861add8dd |
| publicationDate | 2006-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2279432-C2 |
| titleOfInvention | Derivatives of pyridazinoquinoline |
| abstract | FIELD: organic chemistry, medicine, pharmacy. n SUBSTANCE: invention relates to derivatives of pyridazinoquinoline of the formula (II): or their tautomers, or their pharmaceutically acceptable salts wherein ring A represents ortho-condensed phenyl and monosubstituted with R 4 wherein R 4 means halogen atom; R 1 represents -(CH 2 ) n L wherein n means a whole number from 1 to 6; L is chosen from unsubstituted phenyl or its benzo-derivative, or L is chosen from phenyl or its benzo-derivative and substituted with one or two groups chosen from -CN, -CF 3 , (C 1 -C 4 )-alkyl, or L is chosen from -OH, -OCOR', -SO m R' wherein m means 0, 1 or 2, -NR'R'' under condition that -NR'R'' differs from -NH 2 , -NR'COR'', or L is chosen from heterocycle or heteroaryl wherein in each abovementioned case any group from R' or R'' is chosen from hydrogen atom, (C 1 -C 4 )-alkyl, (C 3 -C 6 )-cycloalkyl, phenyl, phenyl-(C 1 -C 4 )-alkyl and wherein any group from R' or R'' is unsubstituted or substituted 1, 2 or 3 times with phenyl, -OH, O-(C 1 -C 4 )-alkyl at carbon atoms wherein in any abovementioned case heterocycle is chosen from five- or six-membered heterocyclic ring comprising 1, 2 or 3 heteroatoms chosen from oxygen (O), nitrogen (N) or sulfur (S) atoms or its condensed benzo-derivative, indicated heterocycle wherein carbon atom is disubstituted to form (C 5 -C 7 )-spiro-group and indicated heterocycle wherein carbon atom © is substituted for oxygen atom (O) to form carbonyl group and wherein in any case heteroaryl is chosen from unsubstituted thiophene, furan, imidazole, triazole, tetrazole. Compounds of the formula (II) are antagonists of glycine-receptors and can be used in preparing pharmaceutical agents designated for treatment or prophylaxis of ischemic disease. n EFFECT: valuable medicinal properties of compounds. n 5 cl, 8 tbl, 148 ex |
| priorityDate | 1993-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 466.